TipRanks
Captor Therapeutics SA (DE:60Q)
STUTTGART:60Q
Germany Market
60Q
Captor Therapeutics SA
RESEARCH TOOLSreports

Captor Therapeutics SA (60Q) Ratios

1 Followers

Captor Therapeutics SA Ratios

DE:60Q's free cash flow for Q2 2026 was zł0.35. For the 2026 fiscal year, DE:60Q's free cash flow was decreased by zł and operating cash flow was zł-8.91. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 5.41 2.27 3.90 3.32 7.57
Quick Ratio
 5.41 2.27 3.90 3.32 7.57
Cash Ratio
 0.17 0.72 1.96 2.83 5.30
Solvency Ratio
 -2.81 -2.27 -1.45 -2.32 -1.73
Operating Cash Flow Ratio
 -5.31 -2.44 -1.58 -1.95 -1.71
Short-Term Operating Cash Flow Coverage
 -34.58 -17.62 -11.52 -20.63 -6.17
Net Current Asset Value
zł 60.29Mzł 17.28Mzł 55.06Mzł 60.57Mzł 84.65M
Leverage Ratios
Debt-to-Assets Ratio
 0.03 0.09 0.06 0.04 0.06
Debt-to-Equity Ratio
 0.04 0.15 0.09 0.05 0.07
Debt-to-Capital Ratio
 0.04 0.13 0.08 0.05 0.07
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.22 1.70 1.36 1.41 1.17
Debt Service Coverage Ratio
 -19.24 -20.84 -10.34 -22.71 -6.57
Interest Coverage Ratio
 -189.69 -188.01 -102.43 -226.06 -66.26
Debt to Market Cap
 <0.01 <0.01 0.01 <0.01 <0.01
Interest Debt Per Share
 0.47 0.70 1.30 0.88 1.81
Net Debt to EBITDA
 >-0.01 0.15 1.02 1.11 2.27
Profitability Margins
Gross Profit Margin
106.78%-13.99%40.59%52.28%77.21%
EBIT Margin
-2470.94%-1141.78%-240.06%-532.22%-385.62%
EBITDA Margin
-2290.93%-1048.05%-208.09%-490.60%-308.16%
Operating Profit Margin
-2534.30%-1141.78%-282.84%-553.11%-418.91%
Pretax Profit Margin
-2206.28%-901.22%-242.82%-534.25%-391.94%
Net Profit Margin
-2207.63%-901.22%-242.82%-534.69%-391.94%
Continuous Operations Profit Margin
-2207.63%-901.22%-242.82%-534.69%-391.94%
Net Income Per EBT
100.06%100.00%100.00%100.08%100.00%
EBT Per EBIT
87.06%78.93%85.85%96.59%93.56%
Return on Assets (ROA)
-55.68%-104.93%-43.92%-72.55%-31.76%
Return on Equity (ROE)
-132.32%-178.86%-59.60%-101.97%-37.26%
Return on Capital Employed (ROCE)
-77.36%-211.89%-66.34%-103.48%-38.51%
Return on Invested Capital (ROIC)
-74.94%-195.82%-61.35%-96.55%-35.84%
Return on Tangible Assets
-56.38%-108.12%-44.13%-72.78%-31.99%
Earnings Yield
-10.13%-10.57%-19.50%-15.19%-5.38%
Efficiency Ratios
Receivables Turnover
 0.74 3.84 0.41 1.05 0.95
Payables Turnover
 0.12 2.09 3.55 0.97 0.49
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.55 0.95 1.79 1.63 0.86
Asset Turnover
 0.03 0.12 0.18 0.14 0.08
Working Capital Turnover Ratio
 0.06 0.12 0.26 0.18 0.09
Cash Conversion Cycle
 -2.58K -79.71 779.48 -29.24 -365.96
Days of Sales Outstanding
 495.10 95.17 882.32 347.53 385.73
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 3.08K 174.87 102.84 376.76 751.69
Operating Cycle
 495.10 95.17 882.32 347.53 385.73
Cash Flow Ratios
Operating Cash Flow Per Share
 -11.69 -6.58 -6.79 -11.24 -5.51
Free Cash Flow Per Share
 -11.75 -6.62 -6.88 -11.88 -5.72
CapEx Per Share
 0.06 0.04 0.09 0.65 0.21
Free Cash Flow to Operating Cash Flow
 1.00 1.01 1.01 1.06 1.04
Dividend Paid and CapEx Coverage Ratio
 -202.17 -172.94 -74.62 -17.37 -25.73
Capital Expenditure Coverage Ratio
 -202.17 -172.94 -74.62 -17.37 -25.73
Operating Cash Flow Coverage Ratio
 -27.59 -10.16 -5.61 -13.82 -3.30
Operating Cash Flow to Sales Ratio
 -36.58 -7.79 -2.00 -3.95 -2.51
Free Cash Flow Yield
-16.73%-9.19%-16.27%-11.88%-3.57%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -8.97 -9.46 -5.13 -6.58 -18.58
Price-to-Sales (P/S) Ratio
 219.74 85.26 12.45 35.19 72.82
Price-to-Book (P/B) Ratio
 6.72 16.92 3.06 6.71 6.92
Price-to-Free Cash Flow (P/FCF) Ratio
 -5.98 -10.88 -6.15 -8.41 -27.97
Price-to-Operating Cash Flow Ratio
 -5.95 -10.94 -6.23 -8.90 -29.06
Price-to-Earnings Growth (PEG) Ratio
 2.57 1.22 0.11 -0.09 -2.04
Price-to-Fair Value
 6.72 16.92 3.06 6.71 6.92
Enterprise Value Multiple
 -9.60 -7.99 -4.96 -6.06 -21.36
Enterprise Value
 441.06M 390.15M 163.48M 392.65M 602.82M
EV to EBITDA
 -9.60 -7.99 -4.96 -6.06 -21.36
EV to Sales
 219.87 83.72 10.33 29.74 65.82
EV to Free Cash Flow
 -5.98 -10.68 -5.10 -7.11 -25.29
EV to Operating Cash Flow
 -6.01 -10.74 -5.17 -7.52 -26.27
Tangible Book Value Per Share
 10.20 4.04 13.75 14.83 22.92
Shareholders’ Equity Per Share
 10.36 4.26 13.84 14.90 23.11
Tax and Other Ratios
Effective Tax Rate
 >-0.01 0.00 0.00 >-0.01 0.00
Revenue Per Share
 0.32 0.84 3.40 2.84 2.20
Net Income Per Share
 -7.05 -7.61 -8.25 -15.19 -8.61
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 0.89 0.79 1.01 1.00 1.02
Research & Development to Revenue
 22.21 9.20 2.19 4.91 4.82
SG&A to Revenue
 3.73 2.08 1.04 1.22 2.14
Stock-Based Compensation to Revenue
 -0.03 0.00 0.13 0.35 0.87
Income Quality
 1.66 0.86 0.82 0.74 0.64
Currency in PLN